Northern Trust’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-587,576
| Closed | -$22.6M | – | 4581 |
|
|
2023
Q2 | $22.6M | Buy |
587,576
+54,472
| +10% | +$1.4M | ﹤0.01% | 1502 |
|
|
2023
Q1 | $12.3M | Sell |
533,104
-708
| -0.1% | -$16.9K | ﹤0.01% | 1881 |
|
|
2022
Q4 | $14M | Buy |
533,812
+111,777
| +26% | +$2.48M | ﹤0.01% | 1784 |
|
|
2022
Q3 | $8.3M | Buy |
422,035
+33,528
| +9% | +$672K | ﹤0.01% | 2120 |
|
|
2022
Q2 | $6.79M | Buy |
388,507
+38,217
| +11% | +$600K | ﹤0.01% | 2305 |
|
|
2022
Q1 | $5.73M | Buy |
350,290
+2,113
| +0.6% | +$28.7K | ﹤0.01% | 2499 |
|
|
2021
Q4 | $5.68M | Buy |
348,177
+44,339
| +15% | +$631K | ﹤0.01% | 2616 |
|
|
2021
Q3 | $3.88M | Sell |
303,838
-2,648
| -0.9% | -$34.9K | ﹤0.01% | 2897 |
|
|
2021
Q2 | $4.33M | Buy |
306,486
+118,249
| +63% | +$1.89M | ﹤0.01% | 2934 |
|
|
2021
Q1 | $2.93M | Sell |
188,237
-10,757
| -5% | -$175K | ﹤0.01% | 3047 |
|
|
2020
Q4 | $3.16M | Buy |
198,994
+61,426
| +45% | +$927K | ﹤0.01% | 2944 |
|
|
2020
Q3 | $1.67M | Sell |
137,568
-13,395
| -9% | -$180K | ﹤0.01% | 3140 |
|
|
2020
Q2 | $1.74M | Buy |
150,963
+5,839
| +4% | +$80.5K | ﹤0.01% | 3110 |
|
|
2020
Q1 | $1.99M | Buy |
145,124
+11,962
| +9% | +$141K | ﹤0.01% | 2862 |
|
|
2019
Q4 | $786K | Sell |
133,162
-12,980
| -9% | -$70.5K | ﹤0.01% | 3462 |
|
|
2019
Q3 | $775K | Sell |
146,142
-5,841
| -4% | -$38.8K | ﹤0.01% | 3457 |
|
|
2019
Q2 | $1.17M | Buy |
151,983
+2,426
| +2% | +$36.9K | ﹤0.01% | 3307 |
|
|
2019
Q1 | $2.98M | Buy |
149,557
+4,855
| +3% | +$84.7K | ﹤0.01% | 2845 |
|
|
2018
Q4 | $1.91M | Sell |
144,702
-5,343
| -4% | -$107K | ﹤0.01% | 3081 |
|
|
2018
Q3 | $5.51M | Buy |
150,045
+10,905
| +8% | +$350K | ﹤0.01% | 2628 |
|
|
2018
Q2 | $4.87M | Buy |
139,140
+44,875
| +48% | +$1.72M | ﹤0.01% | 2697 |
|
|
2018
Q1 | $4.38M | Sell |
94,265
-637
| -0.7% | -$23.3K | ﹤0.01% | 2664 |
|
|
2017
Q4 | $3.56M | Buy |
94,902
+715
| +0.8% | +$31.2K | ﹤0.01% | 2815 |
|
|
2017
Q3 | $5.02M | Buy |
94,187
+3,564
| +4% | +$212K | ﹤0.01% | 2636 |
|
|
2017
Q2 | $5.17M | Buy |
90,623
+11,898
| +15% | +$597K | ﹤0.01% | 2622 |
|
|
2017
Q1 | $4.23M | Buy |
78,725
+679
| +0.9% | +$38.4K | ﹤0.01% | 2655 |
|
|
2016
Q4 | $4.45M | Buy |
78,046
+2,850
| +4% | +$172K | ﹤0.01% | 2622 |
|
|
2016
Q3 | $4.67M | Buy |
75,196
+6,625
| +10% | +$468K | ﹤0.01% | 2556 |
|
|
2016
Q2 | $3.88M | Buy |
68,571
+50,016
| +270% | +$3.04M | ﹤0.01% | 2634 |
|
|
2016
Q1 | $1.19M | Buy |
18,555
+670
| +4% | +$54.2K | ﹤0.01% | 3199 |
|
|
2015
Q4 | $2.52M | Buy |
17,885
+1,016
| +6% | +$138K | ﹤0.01% | 2912 |
|
|
2015
Q3 | $1.63M | Buy |
16,869
+13,629
| +421% | +$1.62M | ﹤0.01% | 3148 |
|
|
2015
Q2 | $491K | Buy |
+3,240
| New | +$535K | ﹤0.01% | 3568 |
|
Northern Trust's KDNY Position: Q3 2023 in Review
Northern Trust sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 587,576 shares — an estimated $22.6M sold.
Northern Trust first reported a position in KDNY in Q2 2015 and held it in 33 quarters. The position peaked at $22.6M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Northern Trust reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Northern Trust sold 587,576 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $22.6M.
- Northern Trust first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 33 quarters.
- Northern Trust's Chinook Therapeutics, Inc. Common Stock position peaked at $22.6M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.